Publications
-
Digestive Diseases and Sciences--past, present, and future.
Keeffe EB,
Dig Dis Sci.
2009;
54
(1):
1-4
-
Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin.
Rossignol JF,
Elfert A, El-Gohary Y, Keeffe EB.
Gastroenterology.
2009;
136
(3):
856-62
-
Clinical course of hepatitis B virus infection during pregnancy.
Nguyen G,
Garcia RT, Nguyen N, Trinh H, Keeffe EB, Nguyen MH.
Aliment Pharmacol Ther.
2009;
29
(7):
755-64
-
Diagnosis and treatment of chronic hepatitis B: 2009 update.
Morgan M,
Keeffe EB.
Minerva Gastroenterol Dietol.
2009;
55
(1):
5-22
-
Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides.
Nguyen MH,
Keeffe EB.
J Viral Hepat.
2009;
16
(3):
149-55
-
Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B virus DNA, and normal alanine aminotransferase levels.
Nguyen MH,
Garcia RT, Trinh HN, Lam KD, Weiss G, Nguyen HA, Nguyen KK, Keeffe EB.
Am J Gastroenterol.
2009;
104
(9):
2206-13
-
Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C.
Vutien P,
Nguyen NH, Trinh HN, Li J, Garcia RT, Garcia G, Nguyen KK, Nguyen HA, Levitt BS, Keeffe EB, Nguyen MH.
Am J Gastroenterol.
2009
-
Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B.
Nguyen LH,
Ha NB, Vutien P, Ha NB, Garcia RT, Trinh HN, Levitt BS, Nguyen HA, Nguyen KK, Keeffe EB, Nguyen MH.
Hepatol Int.
2009
-
Management of chronic hepatitis C treatment failures: role of consensus interferon.
Gonzalez SA,
Keeffe EB.
Biologics.
2009:
3
141-50
-
Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides.
Keeffe EB,
Rossignol JF.
World J Gastroenterol.
2009;
15
(15):
1805-8
-
Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation.
De Luna W,
Sze DY, Ahmed A, Ha BY, Ayoub W, Keeffe EB, Cooper A, Esquivel C, Nguyen MH.
Am J Transplant.
2009;
9
(5):
1158-68
-
Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B.
Bzowej N,
Han S, Degertekin B, Keeffe EB, Emre S, Brown R, Reddy R, Lok AS.
Liver Transpl.
2009;
15
(9):
1010-20
-
Entecavir for the long-term treatment of chronic hepatitis B.
Gonzalez SA,
Keeffe EB.
Expert Rev Anti Infect Ther.
2009;
7
(9):
1053-62
-
Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data.
Holty JE,
Gould MK, Meinke L, Keeffe EB, Ruoss SJ.
Liver Transpl.
2009;
15
(8):
894-906
-
Chronic hepatitis B: preventing, detecting, and managing viral resistance.
Keeffe EB,
Dieterich DT, Pawlotsky JM, Benhamou Y.
Clin Gastroenterol Hepatol.
2008;
6
(3):
268-74
-
Hepatitis B virus genotype: A missing link in transmission risk and disease progression?
Gonzalez SA,
Keeffe EB.
Hepatology.
2008;
47
(5):
1788-90
-
Review article: current antiviral therapy of chronic hepatitis B.
Ayoub WS,
Keeffe EB.
Aliment Pharmacol Ther.
2008;
28
(2):
167-77
-
Advances in Liver Disease: Highlights From the 58th Annual Meeting of the American Association for the Study of Liver Diseases, November 2-6, 2007, Boston, MA.
Keeffe EB,
Duddempudi AT, Jacobson IM.
Rev Gastroenterol Disord.
2008;
8
(1):
58-70
-
Higher rate of sustained virologic response in chronic hepatitis C genotype 6 treated with 48 weeks versus 24 weeks of peginterferon plus ribavirin.
Nguyen MH,
Trinh HN, Garcia R, Nguyen G, Lam KD, Keeffe EB.
Am J Gastroenterol.
2008;
103
(5):
1131-5
-
Management of chronic liver failure until liver transplantation.
Arora G,
Keeffe EB.
Med Clin North Am.
2008;
92
(4):
839-60, ix
-
Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance.
Bhattacharya D,
Katzenstein D, Wong A, Israelski D, Imperial JC, Keeffe EB, Donovan RM.
Int J STD AIDS.
2008;
19
(11):
780-1
-
Are hepatitis B e antigen (HBeAg)-positive chronic hepatitis B and HBeAg-negative chronic hepatitis B distinct diseases?
Nguyen MH,
Keeffe EB.
Clin Infect Dis.
2008;
47
(10):
1312-4
-
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.
Keeffe EB,
Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H.
Clin Gastroenterol Hepatol.
2008;
6
(12):
1315-41; quiz 1286
-
Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4.
Rossignol JF,
Kabil SM, El-Gohary Y, Elfert A, Keeffe EB.
Aliment Pharmacol Ther.
2008;
28
(5):
574-80
-
Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels.
Tsang PS,
Trinh H, Garcia RT, Phan JT, Ha NB, Nguyen H, Nguyen K, Keeffe EB, Nguyen MH.
Clin Gastroenterol Hepatol.
2008;
6
(5):
569-74
-
Is oral L-acyl-carnitine an effective therapy for hepatic encephalopathy? Review of the literature.
Shores NJ,
Keeffe EB.
Dig Dis Sci.
2008;
53
(9):
2330-3
-
Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C.
Rossignol JF,
Keeffe EB.
Future Microbiol.
2008:
3
539-45
-
New and emerging treatment of chronic hepatitis B.
Keeffe EB,
Marcellin P.
Clin Gastroenterol Hepatol.
2007;
5
(3):
285-94
-
Response letter to dr. Morrow et Al.
Reiss GM,
Keeffe EB.
J Am Geriatr Soc.
2007;
55
(1):
142
-
Diagnosis and treatment of chronic hepatitis B: an update.
Morgan M,
Park W, Keeffe EB.
Minerva Gastroenterol Dietol.
2007;
53
(1):
25-41
-
Current indications and contraindications for liver transplantation.
Ahmed A,
Keeffe EB.
Clin Liver Dis.
2007;
11
(2):
227-47
-
Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy.
Arora G,
Keeffe EB.
Rev Gastroenterol Disord.
2007;
7
(2):
63-73
-
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.
Keeffe EB,
Zeuzem S, Koff RS, Dieterich DT, Esteban-Mur R, Gane EJ, Jacobson IM, Lim SG, Naoumov N, Marcellin P, Piratvisuth T, Zoulim F.
Clin Gastroenterol Hepatol.
2007;
5
(8):
890-7
-
Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy.
Berk DR,
Mallory SB, Keeffe EB, Ahmed A.
Clin Gastroenterol Hepatol.
2007;
5
(2):
142-51
-
Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion.
Ha BY,
Ahmed A, Sze DY, Razavi MK, Simpson N, Keeffe EB, Nguyen MH.
Aliment Pharmacol Ther.
2007;
26
(6):
839-46
-
Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
Kohrt HE,
Ouyang DL, Keeffe EB.
Clin Liver Dis.
2007;
11
(4):
965-91, x
-
Future treatment of chronic hepatitis C.
Keeffe EB,
Antivir Ther.
2007;
12
(7):
1015-25
-
Hepatitis B: explosion of new knowledge.
Keeffe EB,
Gastroenterology.
2007;
133
(5):
1718-21
-
The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
Oldfield EC,
Keeffe EB.
Rev Gastroenterol Disord.
2007;
7
(1):
1-21
-
Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
Wong SN,
Reddy KR, Keeffe EB, Han SH, Gaglio PJ, Perrillo RP, Tran TT, Pruett TL, Lok AS.
Liver Transpl.
2007;
13
(3):
334-42
-
Impact of age older than 60 years in living donor liver transplantation.
Kuramitsu K,
Egawa H, Keeffe EB, Kasahara M, Ito T, Sakamoto S, Ogawa K, Oike F, Takada Y, Uemoto S.
Transplantation.
2007;
84
(2):
166-72
-
Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies.
Bhattacharya D,
Imperial JC, Keeffe EB.
Clin Gastroenterol Hepatol.
2006;
4
(3):
288-92
-
Progressive asymptomatic occlusion of a TIPS in a patient with Budd-Chiari syndrome.
Sze DY,
Frisoli JK, Macksood DJ, Dovichi EA, Ahmed A, Keeffe EB.
J Vasc Interv Radiol.
2006;
17
(4):
737-9
-
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.
Keeffe EB,
Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL.
Clin Gastroenterol Hepatol.
2006;
4
(8):
936-62
-
Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
Kohrt HE,
Ouyang DL, Keeffe EB.
Aliment Pharmacol Ther.
2006;
24
(7):
1003-16
-
Do we still need a liver biopsy? Are the serum fibrosis tests ready for prime time?
Crockett SD,
Kaltenbach T, Keeffe EB.
Clin Liver Dis.
2006;
10
(3):
513-34, viii
-
Chronic hepatitis B: a critical appraisal of current approaches to therapy.
Perrillo RP,
Gish RG, Peters M, Keeffe EB, Alberti A, Buti M, Cooksley WG, Fried MW, Hadziyannis SJ, Liaw YF, Naoumov NV, Schiff ER, Thio CL, Tsai N, Schalm S.
Clin Gastroenterol Hepatol.
2006;
4
(2):
233-48
-
Escherichia coli O157:H7 infection in nursing homes: review of literature and report of recent outbreak.
Reiss G,
Kunz P, Koin D, Keeffe EB.
J Am Geriatr Soc.
2006;
54
(4):
680-4
-
Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases.
Keeffe EB,
Trans Am Clin Climatol Assoc.
2006:
117
227-37; discussion 237-8
-
Best of DDW 2006.
Hanauer SB,
Sandborn WJ, Vakil N, Katz PO, Talley NJ, Rex DK, Hawes RH, Guda NM, Freeman ML, Keeffe EB, Balart LA.
Rev Gastroenterol Disord.
2006;
6
(3):
153-89
-
Hepatitis B vaccines.
Yu AS,
Cheung RC, Keeffe EB.
Infect Dis Clin North Am.
2006;
20
(1):
27-45
-
Liver disease: hepatitis B. Treatment of chronic hepatitis B With entecavir.
Keeffe EB,
Rev Gastroenterol Disord.
2006;
6
(2):
112-6
-
[Acute liver failure]
Keeffe EB,
Rev Gastroenterol Mex.
2005 Jan-Mar;
70
(1):
56-62
-
Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirin.
Balan V,
Schwartz D, Wu GY, Muir AJ, Ghalib R, Jackson J, Keeffe EB, Rossaro L, Burnett A, Goon BL, Bowers PJ, Leitz GJ.
Am J Gastroenterol.
2005;
100
(2):
299-307
-
Hematologic side effects of PEG interferon and ribavirin. Management with growth factors.
Keeffe EB,
Kowdley KV.
J Clin Gastroenterol.
2005;
39
(1 Suppl):
S1-2
-
Treatment of chronic hepatitis C in patients coinfected with human immunodeficiency virus and hepatitis C virus.
Keeffe EB,
Rev Gastroenterol Disord.
2005;
5
(2):
107-10
-
Chronic hepatitis C: genotypes 4 to 9.
Nguyen MH,
Keeffe EB.
Clin Liver Dis.
2005;
9
(3):
411-26, vi
-
Hepatitis C virus.
Keeffe EB,
Clin Liver Dis.
2005;
9
(3):
xi-xiii
-
Advancing the clinical treatment of hepatitis B virus.
Keeffe EB,
Semin Liver Dis.
2005:
25 Suppl 1
1
-
Keratins as susceptibility genes for end-stage liver disease.
Ku NO,
Lim JK, Krams SM, Esquivel CO, Keeffe EB, Wright TL, Parry DA, Omary MB.
Gastroenterology.
2005;
129
(3):
885-93
-
Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection.
Crockett SD,
Keeffe EB.
Ann Clin Microbiol Antimicrob.
2005:
4
13
-
Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6.
Nguyen MH,
Keeffe EB.
Clin Gastroenterol Hepatol.
2005;
3
(10 Suppl 2):
S97-S101
-
Chronic hepatitis C: management of treatment failures.
Keeffe EB,
Clin Gastroenterol Hepatol.
2005;
3
(10 Suppl 2):
S102-5
-
Treatment of chronic hepatitis B with peginterferon.
Keeffe EB,
Rev Gastroenterol Disord.
2005;
5
(4):
223-7
-
Role of liver biopsy in the management of chronic liver disease: selective rather than routine.
Reiss G,
Keeffe EB.
Rev Gastroenterol Disord.
2005;
5
(4):
195-205
-
Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination.
Keeffe EB,
Am J Med.
2005:
118 Suppl 10A
21S-27S
-
Antibiotics in the management of hepatic encephalopathy: an evidence-based review.
Rothenberg ME,
Keeffe EB.
Rev Gastroenterol Disord.
2005:
5 Suppl 3
26-35
-
Advances in gastrointestinal pharmacotherapy.
Metz DC,
Vakil N, Keeffe EB, Lichtenstein GR.
Clin Gastroenterol Hepatol.
2005;
3
(12):
1167-79
-
Presidential address during the AGA Plenary Session.
Keeffe EB,
Gastroenterology.
2005;
129
(6):
2096-100
-
Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation.
Fung SK,
Andreone P, Han SH, Rajender Reddy K, Regev A, Keeffe EB, Hussain M, Cursaro C, Richtmyer P, Marrero JA, Lok AS.
J Hepatol.
2005;
43
(6):
937-43
-
Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
Kowdley KV,
Brandhagen DJ, Gish RG, Bass NM, Weinstein J, Schilsky ML, Fontana RJ, McCashland T, Cotler SJ, Bacon BR, Keeffe EB, Gordon F, Polissar N.
Gastroenterology.
2005;
129
(2):
494-503
-
Fulminant hepatic failure secondary to neoplastic infiltration of the liver.
Rajvanshi P,
Kowdley KV, Hirota WK, Meyers JB, Keeffe EB.
J Clin Gastroenterol.
2005;
39
(4):
339-43
-
T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity.
Ichiki Y,
He XS, Shimoda S, Ishibashi H, Keeffe EB, Rossaro L, Gershwin ME.
Autoimmun Rev.
2005;
4
(2):
82-95
-
General management.
Nguyen MH,
Keeffe EB.
Best Pract Res Clin Gastroenterol.
2005;
19
(1):
161-74
-
Portal hypertensive hemorrhage from a left gastroepiploic vein caput medusa in an adhesed umbilical hernia.
Sze DY,
Magsamen KE, McClenathan JH, Keeffe EB, Dake MD.
J Vasc Interv Radiol.
2005;
16
(2 Pt 1):
281-5
-
Occupational risk for hepatitis A: a literature-based analysis.
Keeffe EB,
J Clin Gastroenterol.
2004 May-Jun;
38
(5):
440-8
-
Older age and liver transplantation: a review.
Keswani RN,
Ahmed A, Keeffe EB.
Liver Transpl.
2004;
10
(8):
957-67
-
Liver transplantation for alcoholic liver disease: current concepts and length of sobriety.
Lim JK,
Keeffe EB.
Liver Transpl.
2004;
10
(10 Suppl 2):
S31-8
-
Retreatment of chronic hepatitis C virus infection.
Lim JK,
Imperial JC, Keeffe EB.
Rev Gastroenterol Disord.
2004;
4
(3):
97-103
-
Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9.
Nguyen MH,
Keeffe EB.
Rev Gastroenterol Disord.
2004:
4 Suppl 1
S14-21
-
Chronic hepatitis C with normal aminotransferase levels.
Ahmed A,
Keeffe EB.
Gastroenterology.
2004;
126
(5):
1409-15
-
Hepatitis B virus reactivation with chemotherapy: diagnosis and prevention with antiviral prophylaxis.
Keeffe EB,
Rev Gastroenterol Disord.
2004;
4
(1):
46-8
-
Review article: hepatitis vaccination in patients with chronic liver disease.
Reiss G,
Keeffe EB.
Aliment Pharmacol Ther.
2004;
19
(7):
715-27
-
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.
Keeffe EB,
Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL.
Clin Gastroenterol Hepatol.
2004;
2
(2):
87-106
-
Diagnosis and treatment of chronic hepatitis B.
Park W,
Keeffe EB.
Minerva Gastroenterol Dietol.
2004;
50
(4):
289-303
-
Hepatitis B vaccines.
Yu AS,
Cheung RC, Keeffe EB.
Clin Liver Dis.
2004;
8
(2):
283-300
-
Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis.
Nguyen MH,
Whittemore AS, Garcia RT, Tawfeek SA, Ning J, Lam S, Wright TL, Keeffe EB.
Clin Gastroenterol Hepatol.
2004;
2
(9):
820-4
-
Update on liver transplantation.
Keeffe EB,
Rev Gastroenterol Mex.
2004:
69 Suppl 3
160-70
-
Management of antiviral resistance in patients with chronic hepatitis B.
Locarnini S,
Hatzakis A, Heathcote J, Keeffe EB, Liang TJ, Mutimer D, Pawlotsky JM, Zoulim F.
Antivir Ther.
2004;
9
(5):
679-93
-
Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
Lin OS,
Keeffe EB, Sanders GD, Owens DK.
Aliment Pharmacol Ther.
2004;
19
(11):
1159-72
-
Epidemiology and pathogenesis of primary biliary cirrhosis.
Selmi C,
Invernizzi P, Keeffe EB, Coppel RL, Podda M, Rossaro L, Ansari AA, Gershwin ME, Keefe EB.
J Clin Gastroenterol.
2004;
38
(3):
264-71
-
Hypoglycemic coma in a pregnant woman in association with hepatitis B virus carrier state and hepatocellular carcinoma.
Ahmed A,
Keeffe EB.
J Clin Gastroenterol.
2004;
38
(2):
135-6
-
Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?
Yu AS,
Keeffe EB.
Am J Gastroenterol.
2003;
98
(5):
955-6
-
Update on chronic hepatitis C.
Ahmed A,
Keeffe EB.
Compr Ther.
2003;
29
(4):
224-32
-
Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies.
Ku NO,
Darling JM, Krams SM, Esquivel CO, Keeffe EB, Sibley RK, Lee YM, Wright TL, Omary MB.
Proc Natl Acad Sci U S A.
2003;
100
(10):
6063-8
-
Management of hepatocellular carcinoma.
Yu AS,
Keeffe EB.
Rev Gastroenterol Disord.
2003;
3
(1):
8-24
-
The epidemiology of hepatitis C virus infection.
Yen T,
Keeffe EB, Ahmed A.
J Clin Gastroenterol.
2003;
36
(1):
47-53
-
Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes.
Boisvert J,
Kunkel EJ, Campbell JJ, Keeffe EB, Butcher EC, Greenberg HB.
J Hepatol.
2003;
38
(1):
67-75
-
Hepatitis B virus genotypes in the United States: results of a nationwide study.
Chu CJ,
Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok AS.
Gastroenterology.
2003;
125
(2):
444-51
-
Prevalence of HBV precore/core promoter variants in the United States.
Chu CJ,
Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok AS.
Hepatology.
2003;
38
(3):
619-28
-
Living donor liver transplantation in a patient with hepatic epithelioid hemangioendothelioma.
Simpson ND,
Ahmed AM, Simpson PW, Parkar JA, Keeffe EB, Ahmed A.
J Clin Gastroenterol.
2003;
37
(4):
349-50
-
Systematic review: peginterferon vs. standard interferon in the treatment of chronic hepatitis C.
Zaman A,
Fennerty MB, Keeffe EB.
Aliment Pharmacol Ther.
2003;
18
(7):
661-70
-
Pathogenesis of primary biliary cirrhosis.
Kita H,
Nalbandian G, Keeffe EB, Coppel RL, Gershwin ME.
Clin Liver Dis.
2003;
7
(4):
821-39
-
Peginterferons in hepatitis C virus: virological, pharmacokinetic, and clinical implications. Introduction.
Keeffe EB,
Semin Liver Dis.
2003:
23 Suppl 1
1-2
-
Chronic hepatitis B and hepatitis C in Asian Americans.
Nguyen MH,
Keeffe EB.
Rev Gastroenterol Disord.
2003;
3
(3):
125-34
-
Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant period.
Yu AS,
Keeffe EB.
Clin Liver Dis.
2003;
7
(3):
551-72
-
Patient selection criteria for liver transplantation.
Yu AS,
Keeffe EB.
Minerva Chir.
2003;
58
(5):
635-48
-
Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.
Simpson ND,
Simpson PW, Ahmed AM, Nguyen MH, Garcia G, Keeffe EB, Ahmed A.
J Clin Gastroenterol.
2003;
37
(1):
68-71
-
Screening for hepatocellular carcinoma.
Nguyen MH,
Keeffe EB.
J Clin Gastroenterol.
2002 Nov-Dec;
35
(5 Suppl 2):
S86-91
-
Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties.
Galun E,
Eren R, Safadi R, Ashour Y, Terrault N, Keeffe EB, Matot E, Mizrachi S, Terkieltaub D, Zohar M, Lubin I, Gopher J, Shouval D, Dagan S.
Hepatology.
2002;
35
(3):
673-9
-
Best of the AASLD. Highlights from the 52nd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2001, Dallas, TX.
Keeffe EB,
Davis GL.
Rev Gastroenterol Disord.
2002;
2
(1):
34-40
-
Outcomes of liver transplantation in patients with obesity and patients with inflammatory bowel disease.
Keeffe EB,
Rev Gastroenterol Disord.
2002;
2
(4):
202-4
-
Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.
Nguyen MH,
Garcia RT, Simpson PW, Wright TL, Keeffe EB.
Hepatology.
2002;
36
(2):
410-7
-
Acute pancreatitis after gastrointestinal endoscopy.
Nevins AB,
Keeffe EB.
J Clin Gastroenterol.
2002;
34
(1):
94-5
-
Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.
Fontana RJ,
Keeffe EB, Carey W, Fried M, Reddy R, Kowdley KV, Soldevila-Pico C, McClure LA, Lok AS.
Liver Transpl.
2002;
8
(5):
433-9
-
Immunopathogenesis of primary biliary cirrhosis.
Nishio A,
Keeffe EB, Gershwin ME.
Semin Liver Dis.
2002;
22
(3):
291-302
-
Nonalcoholic fatty liver disease.
Yu AS,
Keeffe EB.
Rev Gastroenterol Disord.
2002;
2
(1):
11-9
-
Viral hepatitis and other infectious diseases in a homeless population.
Cheung RC,
Hanson AK, Maganti K, Keeffe EB, Matsui SM.
J Clin Gastroenterol.
2002;
34
(4):
476-80
-
Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis.
Lai KM,
Millan M, Razavi M, Keeffe EB, Prapong W, Fisher GA, Esquivel CO, So SK.
Transplant Proc.
2001 Feb-Mar;
33
(1-2):
1490-1
-
Advances in liver disease. Highlights from the 51st Annual Meeting of the American Association for the Study of Liver Diseases, October 27-31, 2000, Dallas, TX.
Davis GL,
Keeffe EB.
Rev Gastroenterol Disord.
2001;
1
(1):
42-7
-
Current treatment strategies for chronic hepatitis B and C.
Lin OS,
Keeffe EB.
Annu Rev Med.
2001:
52
29-49
-
Endoscopic gastrointestinal manifestations of liver disease.
Cheung RC,
Cooper S, Keeffe EB.
Gastrointest Endosc Clin N Am.
2001;
11
(1):
15-44
-
Liver transplantation: current status and novel approaches to liver replacement.
Keeffe EB,
Gastroenterology.
2001;
120
(3):
749-62
-
Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection.
Auffermann-Gretzinger S,
Keeffe EB, Levy S.
Blood.
2001;
97
(10):
3171-6
-
Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver.
Boisvert J,
He XS, Cheung R, Keeffe EB, Wright T, Greenberg HB.
J Infect Dis.
2001;
184
(7):
827-35
-
Detection and treatment of coronary artery disease in liver transplant candidates.
Keeffe BG,
Valantine H, Keeffe EB.
Liver Transpl.
2001;
7
(9):
755-61
-
NAFLD and NASH: important diseases before and after liver transplantation.
Yu AS,
Keeffe EB.
Hepatology.
2001;
34
(4 Pt 1):
842-3
-
Hepatitis C virus and liver transplantation.
Ahmed A,
Keeffe EB.
Clin Liver Dis.
2001;
5
(4):
1073-90
-
Quality of life and employment after liver transplantation.
Bravata DM,
Keeffe EB.
Liver Transpl.
2001;
7
(11 Suppl 1):
S119-23
-
Liver transplantation: evolving patient selection criteria.
Yu AS,
Ahmed A, Keeffe EB.
Can J Gastroenterol.
2001;
15
(11):
729-38
-
Liver biopsy in chronic hepatitis C: routine or selective.
Garcia G,
Keeffe EB.
Am J Gastroenterol.
2001;
96
(11):
3053-5
-
Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients.
Teo EK,
Han SH, Terrault N, Luketic V, Jensen D, Keeffe EB, Lok AS.
Hepatology.
2001;
34
(1):
126-32
-
Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation.
Wu SS,
Lin OS, Chen YY, Hwang KL, Soon MS, Keeffe EB.
J Hepatol.
2001;
34
(2):
215-21
-
Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy.
Ahmed A,
Samuels SL, Keeffe EB, Cheung RC.
Am J Gastroenterol.
2001;
96
(1):
233-7
-
Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review.
Bravata DM,
Olkin I, Barnato AE, Keeffe EB, Owens DK.
Liver Transpl.
2001;
7
(3):
191-203
-
Primary biliary cirrhosis: lessons learned from an organ-specific disease.
Nishio A,
Keeffe EB, Gershwin ME.
Clin Exp Med.
2001;
1
(4):
165-78
-
Diagnosis and treatment of primary biliary cirrhosis.
Nishio A,
Keeffe EB, Ishibashi H, Gershwin EM.
Med Sci Monit.
2000 Jan-Feb;
6
(1):
181-93
-
Differential diagnosis of gallstone-induced complications.
Ahmad M,
Cheung RC, Keeffe EB, Ahmed A.
South Med J.
2000;
93
(3):
261-4
-
Liver transplantation in patients with hepatic iron overload: favorable or unfavorable outcome?
Keeffe EB,
Hepatology.
2000;
32
(6):
1396-8
-
A model for a managed care education approach to increase hepatitis awareness: Part. II.
Schiff ER,
Maddrey WC, Keeffe EB.
Manag Care Interface.
2000;
13
(9):
77-9
-
Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease--the LDQOL 1.0.
Gralnek IM,
Hays RD, Kilbourne A, Rosen HR, Keeffe EB, Artinian L, Kim S, Lazarovici D, Jensen DM, Busuttil RW, Martin P.
Am J Gastroenterol.
2000;
95
(12):
3552-65
-
A model for a managed care education approach to increase hepatitis awareness: Part I.
Schiff ER,
Maddrey WC, Keeffe EB.
Manag Care Interface.
2000;
13
(8):
62-4, 69
-
Cost-effective evaluation of acute viral hepatitis.
Ahmed A,
Keeffe EB.
West J Med.
2000;
172
(1):
29-32
-
Management of gallstones and their complications.
Ahmed A,
Cheung RC, Keeffe EB.
Am Fam Physician.
2000;
61
(6):
1673-80, 1687-8
-
End-stage liver disease and liver transplantation: role of lamivudine therapy in patients with chronic hepatitis B.
Keeffe EB,
J Med Virol.
2000;
61
(3):
403-8
-
The immunopathology of primary biliary cirrhosis: thoughts for the millennium.
Sasaki M,
Ansari AA, Nakanuma Y, Coppel RL, Keeffe EB, Gershwin ME.
Arch Immunol Ther Exp (Warsz).
2000;
48
(1):
1-10
-
Liver transplantation at the millennium. Past, present, and future.
Keeffe EB,
Clin Liver Dis.
2000;
4
(1):
241-55
-
Hepatitis A in patients with chronic liver disease - severity of illness and prevention with vaccination.
Keeffe E,
J Viral Hepat.
2000:
7 Suppl 1
15-7
-
Resection versus transplantation for hepatocellular carcinoma.
Esquivel CO,
Keeffe EB, Garcia G, Imperial JC, Millan MT, Monge H, So SK.
J Gastroenterol Hepatol.
1999:
14 Suppl
S37-41
-
Long-term follow-up after liver transplantation in patients with hepatic iron overload.
Tung BY,
Farrell FJ, McCashland TM, Gish RG, Bacon BR, Keeffe EB, Kowdley KV.
Liver Transpl Surg.
1999;
5
(5):
369-74
-
A novel technique for endoscopic removal of expandable biliary Wallstent.
Ahmed A,
Keeffe EB, Imperial JC.
Gastrointest Endosc.
1999;
50
(2):
279-81
-
Risk of tuberculosis in tuberculin skin test-positive liver transplant patients.
Chaparro SV,
Montoya JG, Keeffe EB, Rhee JT, Small PM.
Clin Infect Dis.
1999;
29
(1):
207-8
-
Health-related quality of life after liver transplantation: a meta-analysis.
Bravata DM,
Olkin I, Barnato AE, Keeffe EB, Owens DK.
Liver Transpl Surg.
1999;
5
(4):
318-31
-
Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study Group.
Keeffe EB,
Dusheiko GM, James SP, Mullen KD, Everson GT, Pimstone NR, Donovan J, Albert D.
Cytokines Cell Mol Ther.
1999;
5
(4):
207-10
-
Prednisone withdrawal advocates: beware of recurrent autoimmune hepatitis.
Davila R,
Keeffe EB.
Hepatology.
1999;
30
(1):
338-9
-
Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C. Consensus Interferon Study Group.
Keeffe EB,
Dusheiko GM, Tong MJ, Hollinger FB, Heathcote EJ, McHutchison J, Albert D.
Cytokines Cell Mol Ther.
1999;
5
(4):
211-6
-
Overview of interferon therapy for chronic hepatitis C.
Ahmed A,
Keeffe EB.
Clin Liver Dis.
1999;
3
(4):
757-73
-
Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis?
So SK,
Esquivel CO, Imperial JC, Garcia G, Monge H, Keeffe EB.
J Gastroenterol Hepatol.
1999:
14 Suppl
S48-52
-
Treatment strategies for chronic hepatitis C: update since the 1997 National Institutes of Health Consensus Development Conference.
Ahmed A,
Keeffe EB.
J Gastroenterol Hepatol.
1999:
14 Suppl
S12-8
-
Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.
Ahmed A,
Keeffe EB.
Am J Gastroenterol.
1999;
94
(1):
249-51
-
Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation.
Cacciarelli TV,
Keeffe EB, Moore DH, Burns W, Busque S, Concepcion W, So SK, Esquivel CO.
Arch Surg.
1999;
134
(1):
25-9
-
The successful use of telemedicine in acute variceal hemorrhage.
Ahmed A,
Slosberg E, Prasad P, Keeffe EB, Imperial JC.
J Clin Gastroenterol.
1999;
29
(2):
212-3
-
Are infectious agents involved in primary biliary cirrhosis? A PCR approach.
Tanaka A,
Prindiville TP, Gish R, Solnick JV, Coppel RL, Keeffe EB, Ansari A, Gershwin ME.
J Hepatol.
1999;
31
(4):
664-71
-
Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group.
Jensen DM,
Krawitt EL, Keeffe EB, Hollinger FB, James SP, Mullen K, Everson GT, Hoefs JC, Fromm H, Black M, Foust RT, Pimstone NR, Heathcote EJ, Albert D.
Am J Gastroenterol.
1999;
94
(12):
3583-8
-
Patient selection and listing policies for liver transplantation.
Keeffe EB,
J Gastroenterol Hepatol.
1999:
14 Suppl
S42-7
-
Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection. Consensus Interferon Study Group.
Pockros PJ,
Tong M, Lee WM, van Leeuwen DJ, Keeffe EB, Bala K, Killenberg PG, Foust RT, Rosenblate HJ, Payne KM, Fromm H, Lesesne HR, Black M.
J Viral Hepat.
1998;
5
(4):
271-6
-
Hepatitis B vaccination of patients with chronic liver disease.
Keeffe EB,
Krause DS.
Liver Transpl Surg.
1998;
4
(5):
437-9
-
Liver transplantation at Stanford University Medical Center.
Millan MT,
Keeffe EB, Berquist WE, Castillo RO, Cox KL, Garcia G, Imperial JC, Monge H, So SK, Esquivel CO.
Clin Transpl.
1998:
287-96
-
Re-treatment of chronic hepatitis C with consensus interferon .
Heathcote EJ,
Keeffe EB, Lee SS, Feinman SV, Tong MJ, Reddy KR, Albert DG, Witt K, Blatt LM.
Hepatology.
1998;
27
(4):
1136-43
-
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease.
Keeffe EB,
Iwarson S, McMahon BJ, Lindsay KL, Koff RS, Manns M, Baumgarten R, Wiese M, Fourneau M, Safary A, Clemens R, Krause DS.
Hepatology.
1998;
27
(3):
881-6
-
New approaches to supporting the failing liver.
Cao S,
Esquivel CO, Keeffe EB.
Annu Rev Med.
1998:
49
85-94
-
Allograft rejection after liver transplantation for autoimmune liver diseases.
Hayashi M,
Keeffe EB, Krams SM, Martinez OM, Ojogho ON, So SK, Garcia G, Imperial JC, Esquivel CO.
Liver Transpl Surg.
1998;
4
(3):
208-14
-
Summary of guidelines on organ allocation and patient listing for liver transplantation.
Keeffe EB,
Liver Transpl Surg.
1998;
4
(5 Suppl 1):
S108-14
-
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis.
Shimoda S,
Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, Lake J, Keeffe EB, Roche TE, Gershwin ME.
J Clin Invest.
1998;
102
(10):
1831-40
-
Diabetes and the hepatobiliary system.
Farrell FJ,
Keeffe EB.
Clin Liver Dis.
1998;
2
(1):
119-31, vii
-
Asymptomatic elevation of aminotransferase levels and fatty liver secondary to heterozygous hypobetalipoproteinemia.
Ahmed A,
Keeffe EB.
Am J Gastroenterol.
1998;
93
(12):
2598-9
-
Sclerotherapy versus banding in the treatment of variceal bleeding.
Slosberg EA,
Keeffe EB.
Clin Liver Dis.
1997;
1
(1):
77-84, xi
-
Liver transplantation for alcoholic liver disease: selection and outcome.
Maldonado JR,
Keeffe EB.
Clin Liver Dis.
1997;
1
(2):
305-21
-
Liver transplantation in Asian patients with chronic hepatitis B.
Ho BM,
So SK, Esquivel CO, Keeffe EB.
Hepatology.
1997;
25
(1):
223-5
-
Role of emerging technology in the era of cost containment.
Soetikno R,
Young HS, Keeffe EB.
Gastrointest Endosc Clin N Am.
1997;
7
(2):
331-9
-
Hepatitis G virus: is it a hepatitis virus?
Cheung RC,
Keeffe EB, Greenberg HB.
West J Med.
1997;
167
(1):
23-33
-
Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
Keeffe EB,
Hollinger FB.
Hepatology.
1997;
26
(3 Suppl 1):
101S-107S
-
Milestones in liver transplantation for alcoholic liver disease.
Keeffe EB,
Liver Transpl Surg.
1997;
3
(3):
197-8
-
Comorbidities of alcoholic liver disease that affect outcome of orthotopic liver transplantation.
Keeffe EB,
Liver Transpl Surg.
1997;
3
(3):
251-7
-
Complications of gastrointestinal endoscopy
Young HS,
Keeffe EB.
Gastrointestinal and Liver Disease. 6th ed. Philadelphia:WB Saunders.
1997:
301-309
-
Patterns of hepatitis C viremia in patients receiving hemodialysis.
Umlauft F,
Gruenewald K, Weiss G, Kessler H, Urbanek M, Haun M, Santner B, Koenig P, Keeffe EB.
Am J Gastroenterol.
1997;
92
(1):
73-8
-
Training in endoscopic procedures.
Keeffe EB,
Van Dam J.
J Pediatr Gastroenterol Nutr.
1997;
24
(3):
366
-
Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
Tong MJ,
Reddy KR, Lee WM, Pockros PJ, Hoefs JC, Keeffe EB, Hollinger FB, Hathcote EJ, White H, Foust RT, Jensen DM, Krawitt EL, Fromm H, Black M, Blatt LM, Klein M, Lubina J.
Hepatology.
1997;
26
(3):
747-54
-
Hepatitis G virus: clinical relevance and responsiveness to interferon.
Cheung RC,
Keeffe EB.
Am J Gastroenterol.
1997;
92
(11):
1957-9
-
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.
Lucey MR,
Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, Kneteman NM, Lake JR, Martin P, McDiarmid SV, Rakela J, Shiffman ML, So SK, Wiesner RH.
Liver Transpl Surg.
1997;
3
(6):
628-37
-
Primary liver transplantation without transfusion of red blood cells.
Cacciarelli TV,
Keeffe EB, Moore DH, Burns W, Chuljian P, Busque S, Concepcion W, So SK, Esquivel CO.
Surgery.
1996;
120
(4):
698-704; discussion 704-5
-
Assessment of the alcoholic patient for liver transplantation: comorbidity, outcome, and recidivism.
Keeffe EB,
Liver Transpl Surg.
1996;
2
(5 Suppl 1):
12-20
-
Orthotopic liver transplantation for hepatocellular carcinoma. Factors affecting long-term patient survival.
Ojogho ON,
So SK, Keeffe EB, Berquist W, Concepcion W, Garcia-Kennedy R, Imperial J, Esquivel CO.
Arch Surg.
1996;
131
(9):
935-9; discussion 939-41
-
Gastroenterology in the 21st century--strength in unity: 1996 presidential address.
Keeffe EB,
Gastrointest Endosc.
1996;
44
(4):
505-9
-
Helicobacter pylori infection and blood group antigens: lack of clinical association.
Umlauft F,
Keeffe EB, Offner F, Weiss G, Feichtinger H, Lehmann E, Kilga-Nogler S, Schwab G, Propst A, Grussnewald K, Judmaier G.
Am J Gastroenterol.
1996;
91
(10):
2135-8
-
Colonoscopy preps: what's best?
Keeffe EB,
Gastrointest Endosc.
1996;
43
(5):
524-8
-
Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients.
Gish RG,
Lau JY, Brooks L, Fang JW, Steady SL, Imperial JC, Garcia-Kennedy R, Esquivel CO, Keeffe EB.
Hepatology.
1996;
23
(1):
1-7
-
Diabetic gastroparesis.
Farrell FJ,
Keeffe EB.
Dig Dis.
1995 Sep-Oct;
13
(5):
291-300
-
Hepatotoxicity of transplant immunosuppressive agents.
Kowdley KV,
Keeffe EB.
Gastroenterol Clin North Am.
1995;
24
(4):
991-1001
-
Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression.
Gish RG,
Keeffe EB, Lim J, Brooks LJ, Esquivel CO.
J Hepatol.
1995;
22
(3):
257-62
-
Sedation and analgesia for endoscopy.
Keeffe EB,
Gastroenterology.
1995;
108
(3):
932-4
-
Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis.
Kowdley KV,
Hassanein T, Kaur S, Farrell FJ, Van Thiel DH, Keeffe EB, Sorrell MF, Bacon BR, Weber FL, Tavill AS.
Liver Transpl Surg.
1995;
1
(4):
237-41
-
Liver transplantation for treatment of giant hepatocellular adenomas.
Mueller J,
Keeffe EB, Esquivel CO.
Liver Transpl Surg.
1995;
1
(2):
99-102
-
Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?
Keeffe EB,
Am J Gastroenterol.
1995;
90
(2):
201-5
-
Impact of transjugular intrahepatic portosystemic shunt on orthotopic liver transplantation.
Menegaux F,
Baker E, Keeffe EB, Monge H, Egawa H, Esquivel CO.
World J Surg.
1994 Nov-Dec;
18
(6):
866-70; discussion 870-1
-
Determinants of safe endoscopy.
Keeffe EB,
Gastrointest Endosc.
1994 May-Jun;
40
(3):
379-82
-
Liver transplantation in patients with severe obesity.
Keeffe EB,
Gettys C, Esquivel CO.
Transplantation.
1994;
57
(2):
309-11
-
Pulmonary varices presenting as a solitary lung mass in a patient with end-stage liver disease.
Man KM,
Keeffe EB, Brown CR, Egawa H, Esquivel CO.
Chest.
1994;
106
(1):
294-6
-
Liver transplantation at California Pacific Medical Center, San Francisco, California.
Esquivel CO,
Martinez O, Krams S, Lim J, So SK, Concepcion W, Cox KL, Keeffe EB.
Clin Transpl.
1994:
163-71
-
Outcome of liver transplantation in patients with hemochromatosis.
Farrell FJ,
Nguyen M, Woodley S, Imperial JC, Garcia-Kennedy R, Man K, Esquivel CO, Keeffe EB.
Hepatology.
1994;
20
(2):
404-10
-
Neurological complications of liver transplantation in adult versus pediatric patients.
Menegaux F,
Keeffe EB, Andrews BT, Egawa H, Monge H, Concepcion W, So SK, Esquivel CO.
Transplantation.
1994;
58
(4):
447-50
-
Aortic valve endocarditis after orthotopic liver transplantation.
Egawa H,
Woodley S, Keeffe EB, Concepcion W, Wiviott LD, Menegaux F, Esquivel CO.
Transplantation.
1994;
58
(6):
732-4
-
Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation.
Farrell FJ,
Keeffe EB, Man KM, Imperial JC, Esquivel CO.
Dig Dis Sci.
1994;
39
(10):
2255-9
-
Liver transplantation for uncontrollable variceal bleeding.
Ewaga H,
Keeffe EB, Dort J, Concepcion W, Esquivel CO.
Am J Gastroenterol.
1994;
89
(10):
1823-6
-
Comparison of transjugular and surgical portosystemic shunts on the outcome of liver transplantation.
Menegaux F,
Keeffe EB, Baker E, Egawa H, Concepcion W, Russell TR, Esquivel CO.
Arch Surg.
1994;
129
(10):
1018-23; discussion 1023-4
-
Outcomes and effectiveness research: the 1992 investigator conference of the American Society for Gastrointestinal Endoscopy.
Keeffe EB,
McMahon LF.
Gastrointest Endosc.
1993 Nov-Dec;
39
(6):
840-5
-
Primary sclerosing cholangitis and Hodgkin's disease.
Man KM,
Drejet A, Keeffe EB, Garcia-Kennedy R, Imperial JC, Esquivel CO.
Hepatology.
1993;
18
(5):
1127-31
-
Acute appendicitis secondary to metastatic cholangiocarcinoma.
Man KM,
Keeffe EB, García-Kennedy R, Hansen JE, Verhille MS.
Am J Gastroenterol.
1993;
88
(11):
1966-8
-
Controversies in patient selection for liver transplantation.
Keeffe EB,
Esquivel CO.
West J Med.
1993;
159
(5):
586-93
-
Immunogenicity of two recombinant hepatitis B vaccines in older individuals.
Treadwell TL,
Keeffe EB, Lake J, Read A, Friedman LS, Goldman IS, Howell CD, DeMedina M, Schiff ER, Jensen DM.
Am J Med.
1993;
95
(6):
584-8
-
Comparative effects of blood, colloid, and Ringer's lactate terminal allograft rinse on the results of orthotopic liver transplantation.
Menegaux F,
Egawa H, Keeffe EB, So SK, Concepcion W, Collins GM, Esquivel CO.
Transplant Proc.
1993;
25
(6):
3196-8
Help